| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 665104 | Null | 0.0105972823829604 | 0.4224477 |
| NSC 666112 | Null | 0.0105972823829604 | 0.43232257 |
| NSC 67586 | 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, | 0.0105972823829604 | 0.38199112 |
| NSC 677696 | Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]- tert-butyl ester | 0.0105972823829604 | 0.39393947 |
| NSC 681643 | Camptothecin Derivative | 0.0105972823829604 | 0.23540925 |
| NSC 683086 | Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- | 0.0105972823829604 | 0.27007793 |
| NSC 684496 | Benzoic acid, 4-[2-(3,6-dioxo-1,4-cyclohexadienyl)ethyl]-, isopropyl ester | 0.0105972823829604 | 0.50872361 |
| NSC 699667 | Null | 0.0105972823829604 | 0.34869112 |
| NSC 710716 | Null | 0.0105972823829604 | 0.46320692 |
| NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0105972823829604 | 0.14401518 |